Results 161 to 170 of about 6,765 (189)
Hereditary hemorrhagic telangiectasia.
Jamie, McDonald, Pinar, Bayrak-Toydemir
openaire +1 more source
Hereditary Hemorrhagic Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) describes the presenting manifestations of a disorder that is characterized by pathologic blood vessels. HHT is inherited as an autosomal dominant trait with variable penetrance. The abnormal vascular structures (dysplasias) can affect all the organs in the human body. The link between a physical stimulus and
Thomas, Kühnel +5 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hereditary hemorrhagic telangiectasia
Oral Surgery, Oral Medicine, Oral Pathology, 1965Abstract Two cases of hereditary hemorrhagic telangiectasia in Negro patients have been reported. Both cases could be considered classic with respect to the oral lesions and familial history. Although numerous oral lesions and chronic epistaxis were present, severe, persistent anemia was the primary problem to be dealt with in both cases.
R M, SMITH, M, ROBBINS
openaire +2 more sources
Hereditary Hemorrhagic Telangiectasia
Ophthalmic Plastic & Reconstructive Surgery, 1990A patient with hereditary hemorrhagic telangiectasia and bloody tears is described. This case report serves to familiarize the ophthalmic plastic and reconstructive surgeon with the differential diagnosis of bloody tears. Conjunctival, oral mucosal and cutaneous findings are documented, and the systemic and ocular manifestations of hereditary ...
S H, Goldberg, J D, Bullock
openaire +2 more sources
Schizencephaly in Hereditary Hemorrhagic Telangiectasia
American Journal of Neuroradiology, 2022The presence of malformations of cortical development in patients with hereditary hemorrhagic telangiectasia has been reported on previous occasions. We evaluated a sample of adults with hereditary hemorrhagic telangiectasia for the presence of malformations of cortical development, spatial coincidence of malformations of cortical development and AVMs,
J.J. Gaines +5 more
openaire +2 more sources
Hereditary Hemorrhagic Telangiectasia
New England Journal of Medicine, 1995Identified nearly a century ago, hereditary hemorrhagic telangiectasia, or Rendu–Osler–Weber syndrome, has long been viewed as a rare condition producing minor discomfort for affected persons. However, this disorder is now considered to be more common than previously thought,1–5 and the associated brain and pulmonary lesions are sources of substantial ...
A E, Guttmacher +2 more
openaire +2 more sources
Hereditary Hemorrhagic Telangiectasia
Clinics in Chest Medicine, 2016Hereditary hemorrhagic telangiectasia (HHT) is an underrecognized and underdiagnosed autosomal-dominant angiodysplasia that has an estimated prevalence of 1 in 5000 individuals, with variable clinical presentations even within family members with identical mutations.
openaire +3 more sources
Hereditary Hemorrhagic Telangiectasia and Gastrointestinal Hemorrhage
Gastroenterology, 1963Summary In 1.59 patients with hereditary hemorrhagic telangiectasia, the chief manifestation of the disease was hemorrhage (89 per cent), with epistaxis being most common (81 per cent). The telangiectatic lesions were located primarily on the face, mucous membranes of the head, and hands.
C R, SMITH, L G, BARTHOLOMEW, J C, CAIN
openaire +2 more sources
Hereditary Hemorrhagic Telangiectasia
Archives of Neurology, 1977To the Editor.— The article entitled "Neurologic Aspects of Hereditary Hemorrhagic Telangiectasia" in the February issue of theArchives(34:101, 1977) prompts me to make the following comment. Approximately two years after the publication of my article 1 on the same subject (quoted in the above article), I had the opportunity to study the mother of ...
openaire +2 more sources
Hereditary hemorrhagic telangiectasia/avastin
The Laryngoscope, 2009Abstract This is the first scientific report of hereditary hemorrhagic telangiectasia (HHT) epistaxis treatment by intranasal spraying of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin). Epistaxis in patients with HHT is a morbid, mortal condition that is difficult and unpleasant to manage.
Terence M, Davidson +2 more
openaire +2 more sources

